¼¼°èÀÇ ¿Ü·¡ ¼ö¸é´Ù¿ø°Ë»ç ½Ã½ºÅÛ ½ÃÀå
Ambulatory Polysomnography Systems
»óǰÄÚµå : 1777767
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 386 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,274,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,824,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¿Ü·¡ ¼ö¸é´Ù¿ø°Ë»ç ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 5¾ï 6,950¸¸ ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 4¾ï 5,370¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿Ü·¡ ¼ö¸é´Ù¿ø°Ë»ç ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 3.9%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 5¾ï 6,950¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÃÖ´ë 12 ä³Î PSG ½Ã½ºÅÛÀº CAGR 4.5%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 2¾ï 6,200¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Up to 24 Channel PSG Systems ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 3.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 2,360¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR7.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿Ü·¡ ¼ö¸é´Ù¿ø°Ë»ç ½Ã½ºÅÛ ½ÃÀåÀº 2024³â¿¡ 1¾ï 2,360¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 1¾ï 1,580¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 7.2%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 1.5%¿Í 3.0%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.2%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¿Ü·¡ ¼ö¸é´Ù¿ø°Ë»ç ½Ã½ºÅÛ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿Ü·¡ ¼ö¸é´Ù¿ø°Ë»ç ½Ã½ºÅÛÀÌ ¼ö¸éÀÇ·á¿¡¼­ Á߿伺ÀÌ ³ô¾ÆÁö´Â ÀÌÀ¯´Â?

¿Ü·¡ ¼ö¸é´Ù¿ø°Ë»ç(PSG) ½Ã½ºÅÛÀº ¼ö¸éÀå¾Ö°¡ ÀǽɵǴ ȯÀÚÀÇ »ý¸®Àû ÆÄ¶ó¹ÌÅ͸¦ Á¾ÇÕÀûÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ¾î ¼ö¸éÀÇÇп¡¼­ ¸Å¿ì Áß¿äÇÑ µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ °Ë»ç½Ç ³» ¼ö¸é °Ë»ç¿Í ´Þ¸® ¿Ü·¡ PSG ½Ã½ºÅÛÀº ȯÀÚ°¡ Áý¿¡¼­ ¼ö¸é Æò°¡¸¦ ¹ÞÀ» ¼ö ÀÖ¾î ¼ö¸é ÆÐÅϰú ¼ö¸éÀå¾Ö¿¡ ´ëÇÑ ½ÇÁ¦ µ¥ÀÌÅ͸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀçÅà Áø´ÜÀ¸·ÎÀÇ ÀüȯÀº Æó¼â¼º ¼ö¸é¹«È£ÈíÁõ(OSA), ºÒ¸éÁõ, ÇÏÁöºÒ¾ÈÁõÈıº µî ¼ö¸éÀå¾ÖÀÇ À¯º´·ü Áõ°¡¿Í ½ÉÇ÷°üÁúȯ, ºñ¸¸, Á¤½ÅÁúȯ°úÀÇ ¿¬°ü¼ºÀÌ ³ô¾ÆÁø °ÍÀÌ ±× ¹è°æÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀº ÀÓ»ó ÇöÀåÀÇ Á¦¾à ¾øÀÌ È¯ÀÚÀÇ ¼ö¸é Çൿ¿¡ ´ëÇÑ Á¤È®Çϰí Àå±âÀûÀÎ ÅëÂû·ÂÀ» Á¦°øÇÒ ¼ö ÀÖ´Â Æí¸®ÇÏ°í ºñ¿ë È¿À²ÀûÀÎ Áø´Ü ¼Ö·ç¼ÇÀÇ Çʿ伺À» ÀνÄÇϰí ÀÖ½À´Ï´Ù.

¼ö¸é°ú °ü·ÃµÈ °Ç°­ ¹®Á¦¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó, ȯÀÚ¿Í ÀÇ·á Àü¹®°¡ ¸ðµÎ º¸´Ù °³ÀÎÈ­µÇ°í Ä£¹ÐÇÑ Ä¡·á¸¦ Á¦°øÇϴ ÷´Ü Áø´Ü µµ±¸¸¦ ã°í ÀÖ½À´Ï´Ù. ¿Ü·¡ ¼ö¸é´Ù¿ø°Ë»ç ½Ã½ºÅÛÀº ³úȰµ¿(EEG), ¾È±¸º¯µ¿(EOG), ±ÙÀ°È°µ¿(EMG), È£Èí ³ë·Â, Ç÷Áß »ê¼Ò ³óµµ¸¦ Æ÷ÇÔÇÑ ¿©·¯ »ý¸®Àû ÆÄ¶ó¹ÌÅ͸¦ À¯¿¬ÇÏ°Ô ¸ð´ÏÅ͸µÇÏ¿© ¼ö¸éÀÇ Áú¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ÇコÄÉ¾î ½Ã½ºÅÛÀÌ Á¶±â¹ß°ß°ú ¿¹¹æÀǷḦ Áß½ÃÇÔ¿¡ µû¶ó, ÈÞ´ë°¡ °£ÆíÇÏ°í »ç¿ëÇϱ⠽¬¿î PSG Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀçÅà ¼ö¸é °Ë»çÀÇ ÆíÀǼºÀº ÀÓ»ó ȯ°æ¿¡¼­ ºÒÆíÇÔÀ» °æÇèÇϴ ȯÀڵ鿡°Ô ¸Å·ÂÀûÀ̸ç, ¼ö¸éÀå¾Ö¸¦ º¸´Ù Á¤È®ÇÏ°Ô Æò°¡ÇÏ°í ¼øÀÀµµ¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¿Ü·¡ ¼ö¸é´Ù¿ø°Ë»ç ½Ã½ºÅÛÀ» ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ¿Ü·¡ PSG ½Ã½ºÅÛÀÇ ±â´ÉÀ» Å©°Ô Çâ»ó½ÃÄÑ º¸´Ù È¿À²ÀûÀ̰í ÄÄÆÑÆ®ÇÏ¸ç »ç¿ëÀÚ Ä£È­ÀûÀ¸·Î ¸¸µé¾ú½À´Ï´Ù. ºí·çÅõ½º¿Í °°Àº ¹«¼± ¿¬°á ±â´É°ú Ŭ¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀÇ ÅëÇÕÀº µ¥ÀÌÅÍ ¼öÁý ¹× ºÐ¼®¿¡ Çõ¸íÀ» °¡Á®¿ÔÀ¸¸ç, ¼ö¸é Àü¹®Àǰ¡ ¿ø°ÝÀ¸·Î ȯÀÚ¸¦ ¸ð´ÏÅ͸µÇÏ°í ½Ç½Ã°£ µ¥ÀÌÅ͸¦ È®ÀÎÇÒ ¼ö ÀÖ°Ô Çß½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ» ÅëÇØ ÀÇ·áÁøÀº ¼ö¸éÀå¾Ö¸¦ ½Å¼ÓÇÏ°Ô ÆÄ¾ÇÇÏ°í ±×¿¡ µû¶ó Ä¡·á °èȹÀ» Á¶Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÃֽŠPSG Àåºñ¿¡´Â °³¼±µÈ ¹ÙÀÌ¿À¼¾¼­°¡ žÀçµÇ¾î ȯÀÚÀÇ ºÒÆíÇÔÀ» ÃÖ¼ÒÈ­Çϸ鼭 ¼ö¸é ÆÄ¶ó¹ÌÅÍÀÇ ÃøÁ¤ Á¤È®µµ¸¦ ³ô¿´½À´Ï´Ù.

ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´× ¾Ë°í¸®Áòµµ ¿Ü·¡È¯ÀÚ PSG¿¡¼­ Çõ½ÅÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, µ¥ÀÌÅÍ ºÐ¼®À» ÀÚµ¿È­ÇÏ°í ¼öµ¿ ºÐ¼®À¸·Î´Â °£°úÇÒ ¼ö ÀÖ´Â ÆÐÅÏÀ» ½Äº°ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ AI ±â¹Ý ¼Ö·ç¼ÇÀº ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ ´Ù¾çÇÑ ¼ö¸éÀå¾Ö¸¦ º¸´Ù Á¤È®ÇÏ°Ô ±¸ºÐÇÏ°í º¸´Ù Á¤È®ÇÑ °³ÀÔÀ» ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¿þ¾î·¯ºí ¼¾¼­¸¦ PSG ½Ã½ºÅÛ¿¡ ÅëÇÕÇÔÀ¸·Î½á ¹ø°Å·Î¿î ¹è¼± ¼ö¸¦ ÁÙÀÌ°í ¼ö¸é °Ë»ç Áß À̵¿¼ºÀ» ³ô¿© ȯÀÚÀÇ Æí¾ÈÇÔÀ» ´õ¿í Çâ»ó½ÃÄ×½À´Ï´Ù. ¶ÇÇÑ, ¹èÅ͸® ¼ö¸í°ú °æ·® ¼ÒÀçÀÇ ¹ßÀüÀ¸·Î µ¥ÀÌÅÍ Á¤È®µµ³ª ȯÀÚÀÇ »ç¿ë°¨À» ¶³¾î¶ß¸®Áö ¾Ê°í Àå½Ã°£ ¿Ü·¡ PSG ½Ã½ºÅÛÀ» Âø¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¼ö¸é Á¶»ç°¡ °è¼Ó ÁøÈ­Çϰí ÀÖ´Â °¡¿îµ¥, µðÁöÅÐ Çコ Ç÷§Æû°ú ½º¸¶Æ® ¾Ë°í¸®ÁòÀÇ µµÀÔÀ¸·Î ÀÌµé ±â±âÀÇ Áø´Ü ´É·ÂÀº ´õ¿í °­È­µÉ °ÍÀÔ´Ï´Ù.

¿Ü·¡ ¼ö¸é´Ù¿ø°Ë»ç ½Ã½ºÅÛ ½ÃÀåÀ» Çü¼ºÇÏ´Â »õ·Î¿î Æ®·»µå´Â?

¿Ü·¡È¯ÀÚ ¼ö¸é´Ù¿ø°Ë»ç ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀº ÁøÈ­Çϴ ȯÀÚ ¼±È£µµ¿Í ÇコÄÉ¾î ¿ì¼±¼øÀ§¸¦ ¹Ý¿µÇÏ¿© ¸î °¡Áö »õ·Î¿î Æ®·»µå¸¦ Çü¼ºÇϰí ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ Æ®·»µå Áß Çϳª´Â ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â Äڷγª19 »çÅ·ΠÀÎÇØ ºü¸£°Ô °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â ¼ö¸é °Ë»ç¸¦ ¿ø°ÝÀ¸·Î ¼öÇàÇÏ´Â µðÁöÅÐ °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, ¼ö¸é Ŭ¸®´ÐÀÇ ºÎ´ãÀ» ÁÙÀ̰í ȯÀÚÀÇ Ä¡·á Á¢±Ù¼ºÀ» °³¼±Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ¼ö¸é Àü¹®Àdzª Áø´Ü ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Á¦ÇѵǾî ÀÖ´Â Áö¹æÀ̳ª ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ ƯÈ÷ µÎµå·¯Áö°Ô ³ªÅ¸³ª°í ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ Æ®·»µå´Â º¸´Ù ÀÚ¿¬½º·¯¿î ¼ö¸é °æÇèÀ» Á¦°øÇÏ´Â ¿þ¾î·¯ºí, ºñħ½ÀÀû PSG ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ½º¸¶Æ® ¼¾¼­°¡ ³»ÀåµÈ ¿þ¾î·¯ºí PSG µð¹ÙÀ̽º´Â ¼ö¸é °Ç°­ »óŸ¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇϰíÀÚ ÇÏ´Â ±â¼ú¿¡ Á¤ÅëÇÑ ¼ÒºñÀÚµé »çÀÌ¿¡¼­ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ö¸é ÆÐÅÏ, ½ºÆ®·¹½º ¼öÁØ, °Ç°­ Àü¹Ý¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ÅëÂû·ÂÀ» Á¦°øÇÏ´Â ¸ð¹ÙÀÏ ¾Û°ú ÇÇÆ®´Ï½º ¿þ¾î·¯ºí µî º¸´Ù ±¤¹üÀ§ÇÑ À£´Ï½º ÃßÀû ¼Ö·ç¼Ç°ú ¼ö¸é Áø´ÜÀ» ÅëÇÕÇÏ´Â °Í¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ±ÔÁ¦ ±â°ü°ú ÀÇ·á ´Üü´Â ¶ÇÇÑ ¿Ü·¡ PSG ½Ã½ºÅÛÀÌ ÀÓ»ó µî±ÞÀÇ Á¤È®µµ¸¦ ÃæÁ·Çϰí ÀÇ·á Ç¥ÁØÀ» ÁؼöÇÏ´Â °ÍÀ» º¸ÀåÇϱâ À§ÇØ °¡Á¤ ¼ö¸é Áø´ÜÀÇ Ç¥ÁØÈ­¸¦ ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ¼ö¸é °Ç°­¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Æí¸®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿Ü·¡ ¼ö¸é´Ù¿ø°Ë»ç ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

¿Ü·¡ ¼ö¸é´Ù¿ø°Ë»ç ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀº ÈÞ´ë¿ë ¼ö¸é ¸ð´ÏÅ͸µ ±â¼úÀÇ ¹ßÀü, ¼ö¸éÀå¾Ö¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¿ø°Ý ÀÇ·á ¼Ö·ç¼ÇÀÇ Ã¤Åà Ȯ´ë µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý Ç÷§Æû°ú AI¸¦ Ȱ¿ëÇÑ ºÐ¼®ÀÌ ´ëÁßÈ­µÇ¸é¼­ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â º¸´Ù ³ôÀº Á¤È®µµ¿Í È¿À²¼ºÀ¸·Î ¿ø°ÝÁö¿¡¼­ ¼ö¸é °Ë»ç¸¦ ½Ç½ÃÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Áý¿¡¼­ ºñħ½ÀÀû Áø´Ü ¼Ö·ç¼ÇÀ» ¼±È£ÇÏ´Â ¼ÒºñÀÚ ÇൿÀÇ º¯È­µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñ¸¸, °íÇ÷¾Ð, ½ºÆ®·¹½º °ü·Ã Áúȯ µî »ýȰ½À°ü °ü·Ã °Ç°­ ¹®Á¦ ¹ß»ý·üÀÌ Áõ°¡Çϸ鼭 ÀáÀçÀûÀÎ °Ç°­ À§ÇèÀ» Á¶±â¿¡ ¹ß°ßÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ ¼ö¸é ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼ö¸é Ŭ¸®´Ð°ú Àü¹® Áø´Ü¼¾ÅÍÀÇ È®´ë, ¼ö¸é °Ç°­ ÀνÄÀ» ³ôÀ̱â À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀÌ µðÁöÅÐ °Ç°­ ¼Ö·ç¼Ç°ú ÀçÅà Áø´ÜÀ» Áö¼ÓÀûÀ¸·Î µµÀÔÇÔ¿¡ µû¶ó, ¿Ü·¡ ¼ö¸é´Ù¿ø°Ë»ç ½Ã½ºÅÛ ½ÃÀåÀº ÁøÈ­Çϴ ȯÀÚ ´ÏÁî¿Í ±â¼ú Çõ½Å¿¡ ÈûÀÔ¾î Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ºÎ¹®

Á¦Ç°(ÃÖ´ë 12ä³Î PSG ½Ã½ºÅÛ, ÃÖ´ë 24ä³Î PSG ½Ã½ºÅÛ, ÃÖ´ë 32ä³Î PSG ½Ã½ºÅÛ, 32ä³Î PSG ½Ã½ºÅÛ ÀÌ»ó), ¿ëµµ(Æó¼â¼º ¼ö¸é¹«È£ÈíÁõ ¿ëµµ, ¸¸¼º ºÒ¸éÁõ ¿ëµµ, ±â¸éÁõ ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(¼ö¸é ¿¬±¸¼Ò ¿ëµµ, º´¿ø ¿ëµµ, ȨÄɾî ȯ°æ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Ambulatory Polysomnography Systems Market to Reach US$569.5 Million by 2030

The global market for Ambulatory Polysomnography Systems estimated at US$453.7 Million in the year 2024, is expected to reach US$569.5 Million by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Up to 12 Channel PSG Systems, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$262.0 Million by the end of the analysis period. Growth in the Up to 24 Channel PSG Systems segment is estimated at 3.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$123.6 Million While China is Forecast to Grow at 7.2% CAGR

The Ambulatory Polysomnography Systems market in the U.S. is estimated at US$123.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$115.8 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Ambulatory Polysomnography Systems Market - Key Trends & Drivers Summarized

Why Are Ambulatory Polysomnography Systems Gaining Importance in Sleep Medicine?

Ambulatory polysomnography (PSG) systems have become a crucial tool in sleep medicine, enabling comprehensive monitoring of physiological parameters in patients suspected of having sleep disorders. Unlike traditional in-lab sleep studies, ambulatory PSG systems allow patients to undergo sleep evaluations in their home environment, capturing real-world data on sleep patterns and disturbances. This shift towards home-based diagnostics is driven by the rising prevalence of sleep disorders such as obstructive sleep apnea (OSA), insomnia, and restless leg syndrome, which are increasingly linked to cardiovascular diseases, obesity, and mental health conditions. Healthcare providers are recognizing the need for convenient and cost-effective diagnostic solutions that can provide accurate, long-term insights into patients' sleep behaviors without the limitations of clinical settings.

The growing awareness of sleep-related health issues has prompted both patients and healthcare professionals to explore advanced diagnostic tools that provide more personalized and accessible care. Ambulatory polysomnography systems offer the flexibility to monitor multiple physiological parameters, including brain activity (EEG), eye movement (EOG), muscle activity (EMG), respiratory effort, and blood oxygen levels, providing a comprehensive analysis of sleep quality. As healthcare systems globally emphasize early detection and preventive care, the demand for portable and easy-to-use PSG devices is rising. Furthermore, the convenience of at-home sleep testing is appealing to patients who experience discomfort in clinical environments, leading to increased compliance and more accurate assessments of sleep disorders.

How Are Technological Advancements Transforming Ambulatory Polysomnography Systems?

Technological advancements have significantly enhanced the capabilities of ambulatory PSG systems, making them more efficient, compact, and user-friendly. The integration of wireless connectivity features such as Bluetooth and cloud-based platforms has revolutionized data collection and analysis, allowing sleep specialists to remotely monitor patients and review real-time data. These innovations enable healthcare providers to identify sleep disturbances promptly and adjust treatment plans accordingly. Additionally, modern PSG devices are equipped with improved biosensors that offer greater accuracy in measuring sleep parameters while ensuring minimal discomfort for the patient.

Artificial intelligence (AI) and machine learning algorithms are also playing a transformative role in ambulatory PSG, automating data interpretation and identifying patterns that might be overlooked through manual analysis. These AI-driven solutions help healthcare providers differentiate between various sleep disorders with higher precision, leading to more targeted interventions. The integration of wearable sensors into PSG systems has further improved patient comfort by reducing the number of cumbersome wires and enhancing mobility during sleep studies. Moreover, advancements in battery life and lightweight materials are ensuring that ambulatory PSG systems can be worn for extended periods without compromising data accuracy or patient experience. As sleep research continues to evolve, the incorporation of digital health platforms and smart algorithms is set to further enhance the diagnostic capabilities of these devices.

What Are the Emerging Trends Shaping the Ambulatory Polysomnography Systems Market?

Several emerging trends are shaping the growth of the ambulatory polysomnography systems market, reflecting evolving patient preferences and healthcare priorities. One of the most significant trends is the growing adoption of telemedicine and remote patient monitoring, which have seen rapid acceleration due to the COVID-19 pandemic. Patients and healthcare providers are increasingly relying on digital health solutions to conduct sleep studies remotely, reducing the burden on sleep clinics and improving patient access to care. This trend is particularly evident in rural and underserved areas where access to sleep specialists and diagnostic facilities is limited.

Another important trend is the increasing demand for wearable and non-intrusive PSG solutions that offer a more natural sleep experience. Wearable PSG devices embedded with smart sensors are becoming more popular among tech-savvy consumers who seek continuous monitoring of their sleep health. Additionally, there is a rising focus on integrating sleep diagnostics with broader wellness tracking solutions, including mobile apps and fitness wearables that provide holistic insights into sleep patterns, stress levels, and overall health. Regulatory bodies and healthcare organizations are also driving the standardization of home-based sleep diagnostics, ensuring that ambulatory PSG systems meet clinical-grade accuracy and compliance with healthcare standards. As patient awareness of sleep health continues to rise, the demand for convenient and reliable diagnostic solutions is expected to grow exponentially.

What Are the Key Factors Driving the Growth of the Ambulatory Polysomnography Systems Market?

The growth in the ambulatory polysomnography systems market is driven by several factors, including advancements in portable sleep monitoring technologies, increasing awareness of sleep disorders, and the growing adoption of remote healthcare solutions. The widespread availability of cloud-based platforms and AI-driven analytics has enabled healthcare providers to conduct sleep studies remotely with greater accuracy and efficiency. Changing consumer behavior, characterized by a preference for home-based and non-invasive diagnostic solutions, is also contributing to market expansion. Additionally, the rising incidence of lifestyle-related health issues such as obesity, hypertension, and stress-related disorders is driving demand for continuous sleep monitoring to detect potential health risks early. The expansion of sleep clinics and specialized diagnostic centers, along with government initiatives promoting sleep health awareness, is further fueling market growth. As healthcare providers continue to embrace digital health solutions and home-based diagnostics, the ambulatory polysomnography systems market is poised for sustained growth, driven by evolving patient needs and technological innovation.

SCOPE OF STUDY:

The report analyzes the Ambulatory Polysomnography Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Up to 12 Channel PSG Systems, Up to 24 Channel PSG Systems, Up to 32 Channel PSG Systems, Above 32 Channel PSG Systems); Application (Obstructive Sleep Apnea Application, Chronic Insomnia Application, Narcolepsy Application, Other Applications); End-Use (Sleep Laboratories Application, Hospitals Application, Home Care Settings Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â